Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease
March 03, 2017 15:39 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 3, 2017) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Publishes Promising Paper on Novel Treatment for Allergic Airway Disease
October 13, 2016 20:31 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 13, 2016) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...
Qu Biologics Closes Private Financing of CDN$4 Million
April 12, 2016 11:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 12, 2016) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Awarded Genome BC Funding to Study QBECO Site Specific Immunomodulator (SSI) for Ulcerative Colitis
April 06, 2016 10:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 6, 2016) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Announces Initial Results in Randomized, Placebo-Controlled Crohn's Disease Clinical Trial
March 21, 2016 08:30 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 21, 2016) - Qu Biologics Inc., an immunotherapy company developing Site Specific Immunomodulators (SSIs) for cancer and other inflammatory...
Qu Biologics Closes Oversubscribed Financing; Crohn's Disease Phase 2 Clinical Trial Results in First Quarter 2016
December 23, 2015 09:05 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 23, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore the body's...
Qu Biologics Completes Enrollment of Randomized Clinical Trial in Crohn's Disease
November 24, 2015 08:20 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 24, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted Three New Patents for Treating Inflammatory Bowel Disease, Colon Cancer and Skin Cancer
November 17, 2015 17:20 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 17, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Granted U.S. Patent for Use of Staphylococcus Aureus-Based Immunotherapies to Treat Melanoma
September 29, 2015 09:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 29, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...
Qu Biologics Opens Additional Ulcerative Colitis Clinical Trial Sites in Edmonton and Hamilton
August 31, 2015 09:00 ET
|
Qu Biologics
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 31, 2015) - Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune...